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The retinoblastoma tumor suppressor protein pRb is
a master regulator of cellular proliferation, principally
through interaction with E2F and regulation of E2F
target genes. Here, we describe the H1.2 linker his-
tone as amajor pRb interaction partner. We establish
that H1.2 and pRb are found in a chromatin-bound
complex on diverse E2F target genes. Interrogating
the global influence of H1.2 on the genome-wide
distribution of pRb indicated that the E2F target
genes affected by H1.2 are functionally linked to
cell-cycle control, consistent with the ability of H1.2
to hinder cell proliferation and the elevated levels of
chromatin-bound H1-pRb complex, which occur in
growth-arrested cells. Our results define a network
of E2F target genes as susceptible to the regulatory
influence of H1.2, where H1.2 augments global
association of pRb with chromatin, enhances tran-
scriptional repression by pRb, and facilitates pRb-
dependent cell-cycle arrest.
INTRODUCTION
The replication-dependent linker H1 histones are generally
believed to be involved in repressing gene expression through
compacting chromatin into higher order structures (Misteli
et al., 2000). There are seven somatic H1 subtypes in human
cells (H1.1 to H1.5, H1.0, and H1X) that exhibit considerable
sequence divergence in the tail regions (Harshman et al.,
2013). Because of the differences in intracellular localization
and levels between cell types, it has been speculated that H1
subtypes take on different functional roles in addition to the
established general effects on chromatin compaction (Biterge
and Schneider, 2014). It has been reported that H1.2 associates
with a stable protein complex that influences p53 activity (Kim
et al., 2012), and murine H1B (equivalent to human H1.2) inter-Cell
This is an open access article under the CC BY-Nacts with the homeobox protein MSX1 to prevent activation of
the MYOD gene, thereby delaying myoblast differentiation (Lee
et al., 2004), suggestive of gene-specific regulatory effects.
Despite the generally held view that the principal role of H1 his-
tone is to dampen transcription and maintain transcriptional
inactivity, some studies have highlighted a role in transcriptional
activation (Clausell et al., 2009; Kim et al., 2013). For example,
H1-containing chromatin is remodeled by SWI/SNF (switch/su-
crose non-fermentable) complexes (Clausell et al., 2009), and
H1.2 stably interacts with CUL4A and PAF1 to generate active
chromatin (Kim et al., 2013). Thus, it appears that H1 histones
are generally dedicated to repressive roles in gene expression,
although transcription-factor-specific roles are likely.
The pRb tumor suppressor protein acts as an important gate-
keeper in regulating cell-cycle transition through G1 into
S phase, and mutation in the Rb gene represents one of the
most frequent events in human cancer, contributing to cancer
initiation and progression (Munro et al., 2012). Mechanistically,
pRb is a transcriptional regulator with its principal target
being the E2F family of transcription factors. The E2F family reg-
ulates various target genes involved with cell-cycle progression
and diverse cell fates, which thereby allows pRb to influence
numerous aspects of cell biology.
In this study, we uncover a role for the H1.2 linker histone in
directing the genome-wide association of pRb with chromatin.
We have found that H1.2 interacts with pRb and thereby facili-
tates pRb binding near E2F target genes. Our results suggest a
selective role for histone H1.2, mediated through modulating
the chromatin-binding properties of pRb, which, in turn, allows
H1.2 to exert global effects on the E2F gene network and thereby
influence cell-cycle control.RESULTS
Linker H1 Histones in the pRb Interactome
We generated Tet-On stable cell lines that, upon induction, ex-
pressed FLAG-pRb 1-379, 379-928, or wild-type (WT) 1-928
(Figure 1A, i and ii). All three pRb derivatives displayed a nuclearReports 19, 2193–2201, June 13, 2017 ª 2017 The Author(s). 2193
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. pRb Interacts with Linker Histone H1.2
(A) (i) Diagram of pRb with the A and B domains of the pocket shown in blue. The N- and C-terminal regions are also indicated. (ii) U2OS Tet-On-inducible cells
expressing pTRE2 control vector, FLAG-pRb 1-379, FLAG-pRb 379-928, and FLAG pRb 1-928 were grown with (+) or without (-) doxycycline (1 mg/mL) for 48 hr.
Cell lysates were prepared and immunoblotted with FLAG and actin antibodies. (iii) U2OS Tet-On-inducible cells expressing FLAG-pRb 1-379, FLAG-pRb
379-928, and FLAG pRb 1-928 or pTRE2 empty vector were seeded at a density of 1 3 104. Cell counts were performed at 3 and 5 days (d). Graph indicates
average ± SD (n = 3; **p < 0.01, Student’s t test).
(legend continued on next page)
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localization in induced cells (Figure S1A, i), and caused growth
suppression in cell-proliferation assays, with fewer cells evident
in the pRb-induced compared to the induced control cell line
(Figure 1A, iii). The WT, 379-928, and 1-379 cells each exhibited
varying levels of growth inhibition, with WT pRb exhibiting the
most significant level (Figure 1A, iii). Notably, pRb 1-379 was
also quite active, compared to the control cell line in a colony for-
mation assay (Figure S1B, i and ii).
Given that the ability of pRb to inhibit cell proliferation is
principally attributed to its pocket region (379-928), we were
intrigued that the N-terminal domain could also suppress cell
proliferation, and because the N-terminal domain is poorly char-
acterized, we next used mass spectrometry to identify pRb-in-
teracting proteins, focusing on the pRb 1-379 region. A number
of proteins were identified that co-purified with FLAG-pRb 1-379
but not the empty vector control (Figure 1B, iii). We were
intrigued by the presence of the linker H1 histone family,
including H1.2 and H1.4 (Figure 1B, i and iii), which prompted
us to further explore the role of H1. For this, chromatin bound
to pRb was purified from FLAG-pRb 1-379-inducible cells,
where approximately 5%of the total cellular pRb remained chro-
matin bound (Figure S1C). Mass spectrometry of the pRb-asso-
ciated chromatin similarly revealed the presence of H1 histones,
including H1.4, H1.2, H1.1, H1.0, and H1x, together with the core
histones H2B and H4 (Figure 1B, iii).
We verified that the interaction between pRb and H1 histones
occurred in cells, focusing on subtypes H1.2 and H1.4 (we were
restricted to investigating these two H1 subtypes due a lack of
other suitable subtype-specific antibodies) by immunoprecipita-
tion of pRb from both FLAG-pRb-inducible cells and cells trans-
fected with HA (hemagglutinin)-pRb 1-379, where an interaction
was evident (Figure 1C, i and ii). Additionally, endogenous pRb
was found to immunoprecipitate with ectopic H1 subtypes (Fig-
ure 1C, iii), and an interaction between endogenous pRb and
H1.2 was evident in a number of cell types (Figures 1D, i and ii,
and S1D). However, because pRb and H1 histones are chro-
matin associated, it was necessary to rule out that the interaction(B) In (i), FLAG-pRb 1-379-inducible cells were grown with (+) or without (-) dox
elution with FLAG peptide. The eluted protein complexes were subjected to silve
and subjected to tryptic digestion and nano-liquid chromatography-tandemmass
isolated from FLAG-pRb (1-379) or pTRE2 control cells (both grown in the prese
elution with FLAG peptide. 20% of each eluted immunocomplexes was analyzed
80% of the eluates were subjected to in-solution tryptic digestion, and proteins
noprecipitated from the control vector cell line and pRb 1-379 allowed the ide
identified as pRb 1-379-interacting proteins by mass spectrometry in pRb-associ
Mascot scores. Previously reported interacting proteins are highlighted in red; for
et al., 1998; Takemura et al., 2002).
(C) In (i), FLAG-pRb 1-379-inducible cells were grown in the presence of doxycycl
immunoblotting with H1.2, H1.4, or FLAG antibodies. (ii) U2OS cells were transfe
were prepared, and HA-pRb was then immunoprecipitated, followed by immu
transfected with FLAGH1.1, FLAGH1.2, or control vector. 48 hr post-transfection
with pRb and FLAG antibodies.
(D) In (i), U2OS cell lysates were immunoprecipitated with non-specific (NS) or pR
that the blot has been spliced between input and IP, as different exposures were r
immunoprecipitated with non-specific (NS) or pRb antibodies, followed by immu
(E) GST-H1.2, GST-H1.4, or GSTwere incubated in the presence of bacterially exp
extensive washes, immunoblotting was performed with GST and His antibodies.
(F) U2OS cells were transfectedwith the indicated HA-tagged pRbN-terminal trun
followed by immunoblotting with H1.2 and HA antibodies.was mediated indirectly through a separate association of each
protein with DNA. We pre-incubated cell lysates with DNase to
digest any DNA prior to immunoprecipitation, which actually
enhanced the interaction between pRb and H1.2, therefore
suggesting that the interaction is not bridged by DNA (Fig-
ure S1E). Furthermore, we expressed and purified recombinant
GST (glutathione S-transferase)-H1.2, GST-H1.4, and His-pRb
1-379 and performed in vitro GST and Ni-NTA binding assays,
where His-pRb bound efficiently to GST-H1.2 or GST-H1.4,
but not to GST alone (Figures 1E and S1F), suggesting a specific
and direct interaction between pRb and histone H1 subtypes
H1.2 and H1.4. We also studied which region of pRb interacts
with H1.2. Truncations of HA-tagged pRb were expressed, and
the ability to associate with endogenous H1.2 was assessed.
While no binding of H1.2 to pRb 1-100 was evident, we observed
that H1.2 could associate with other derivatives of pRb (including
the low-penetrant point mutant R661W) (Figure S1G). It is
consistent with a role for the N-terminal region of pRb for H1.2
binding that deleting the first 126 amino-acid residues of pRb
in the context of the full-length protein prevented the interaction
with H1.2 (Figure 1F); nuclear accumulation of pRb 126-928
occurred as expected (Figure S1H). Thus, the N-terminal region
of pRb is responsible for the interaction with H1.2.
H1Histones Associate with the Promoters of E2F Target
Genes
Because pRb binds to E2F, we next examined whether H1 his-
tones are present in the chromatin environment of E2F target
genes. FLAG-tagged H1 subtypes were expressed in U2OS
cells, and chromatin immunoprecipitation (ChIP) analysis was
performed (Figure S2A, i). All of the H1 subtypes examined
were detected in the region of the E2F-binding site on a number
of target genes (Figure S2A, ii). We then addressed whether pRb
and H1 coexist in a chromatin-bound complex, which we tested
by performing sequential ChIP analyses. We detected endoge-
nous pRb and H1.2 as a chromatin-bound complex on E2F
target genes in diverse cell types (Figures 2A, i and ii, andycycline for 48 hr. FLAG immunoprecipitation (IP) was performed followed by
r staining, and bands of notable difference (indicated by arrows) were excised
spectrometry (nano-LC-MS/MS). Mol wt, molecular weight. (ii) Chromatin was
nce of doxycycline). FLAG immunoprecipitations were performed, followed by
by electrophoresis, and silver staining of the gel was performed. The remaining
were identified using nano-LC-MS/MS. Comparison between proteins immu-
ntification of proteins that selectively bound to pRb 1-379. (iii) Proteins were
ated chromatin, and whole-cell extracts are listed in tabular form, together with
example, nucleophosmin, MCM7, and nucleolin (Grinstein et al., 2006; Sterner
ine for 48 hr. Cell lysates were immunoprecipitated with anti-FLAG, followed by
cted with HA-pRb 1-379 or control vector. 48 hr post-transfection, cell lysates
noblotting with antibodies against H1.2, H1.4, or HA. (iii) U2OS cells were
, lysates were immunoprecipitated with anti-FLAG, followed by immunoblotting
b antibodies, followed by immunoblotting with H1.2 and pRb antibodies (note
equired to show input and IP at appropriate levels). (ii) MCF-7 cell lysates were
noblotting with H1.2 and pRb antibodies.
ressed His-pRb (1-379) together with Glutathione Sepharose beads. Following
cations. 48 hr post-transfection, lysates were immunoprecipitated with anti-HA,
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Figure 2. H1.2 Regulates Chromatin-Bound pRb and E2F Target Gene Expression
(A) In (i), chromatin fromT98Gcellswas immunoprecipitatedwithcontrol immunoglobulinG (IgG) or pRbantibodies. A sequential re-immunoprecipitation (re-IP)was
performedwith eluted IgGandpRbmaterialwithcontrol IgGorH1.2 antibodies. Thepresenceof theH1/pRbcomplexon theDHFRpromoterwasanalyzedbyqPCR.
Graphs indicate average ± SD (n = 3; **p < 0.01, Student’s t test). (ii) Chromatin fromMCF7 cells was immunoprecipitated with control IgG, pRb, or H1.2 antibodies.
A sequential re-IP was performed with eluted pRb material with control IgG, H1.2, or E2F-1 antibodies. The binding of the complex to the CDC6 promoter was
analyzed by PCR. E2F-1 was included as a positive control for the pRb ChIP-reIP. Quantification of the ChIP signal is shown in graphical format below.
(B) MCF7 cells were transfected with GFP or H1.2 siRNA (20 nM) for 72 hr. ChIP was performed with control IgG and pRb antibodies. ChIP activity on E2F
promoters was assessed by qPCR. Corresponding immunoblot is shown on the right. *p < 0.05; **p < 0.01, Student’s t test. Graph indicates mean ± SEM (n = 5).
(C) U2OS cells were transfected with GFP or H1.2 siRNA (20 nM) for 72 hr. E2F target gene RNA levels were assessed by qPCR. Transcript levels were normalized
to housekeeping gene GAPDH. Corresponding immunoblot is shown on the right. Graph indicates average ± SD (n = 3; *p < 0.05; **p < 0.01, Student’s t test).
(D) Venn diagram showing the overlap of pRb peaks between treatment conditions; namely, siGFP control conditions (+ H1.2) and H1.2 knockdown (H1.2). The
siGFP treatment (red) yielded 1,650 pRb peaks, and the siH1.2 treatment (blue) yielded 708 peaks. There were 670 shared peaks (purple) between the two
conditions, and 980 and 38 peaks unique to each condition, respectively.
(E) Motif analysis of the most enriched de novo peak identified in the siGFP and siH1.2 condition and among peaks unique to the siGFP condition.
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Figure 3. H1.2 Regulates the Genome-wide Association of pRb with Chromatin
(A) Heatmap analysis of pRb binding around transcription start sites (TSSs) under siH1.2 or siGFP treatment. Each panel represents 2,000 bp upstream and
2,000 bp downstream of the transcription start site.
(legend continued on next page)
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S2B). Further, depletion of H1.2 resulted in a reduction in the
amount of chromatin-bound pRb on a variety of E2F target genes
(Figure 2B). Significantly, the expression of the E2F target genes
increased upon H1.2 depletion (Figure 2C). Moreover, H1.2
expression augmented the E2F1 transcriptional repression
mediated by pRb in reporter-based assays (Figure S2C). Overall,
pRb and H1.2 co-exist in the chromatin environment of
E2F target genes, where H1.2 contributes to transcriptional
inactivation.
In order to clarify whether H1 histones have a global effect on
pRb, we performed a genome-wide chromatin-binding analysis
by ChIP sequencing (ChIP-seq). We used MCF7 cells, which ex-
press WT pRb, and studied the genome-wide distribution of the
pRb ChIP complex, as well as the impact that H1.2 has on the
genomic distribution of pRb. Initially, we confirmed that
the ChIP enrichment was specific to pRb by generating MCF7
CRISPR cells that lack pRb; there was no detectable pRb signal
apparent upon the E2F1 promoter in pRb/ cells compared
to their WT counterparts (Figure S2D). Endogenous pRb was
immunoprecipitated from MCF7 cells that had been treated
with either a control or an H1.2 small interfering (si)RNA (siRNA).
Chromatin was isolated, libraries prepared, and the DNA was
subjected to deep sequencing. We identified 1,650 and 708 spe-
cific peaks in the control siRNA and the H1.2 siRNA, respec-
tively, with an overlap of 670 peaks (Figure 2D). As anticipated,
a very strong enrichment of the E2F binding-site motif was iden-
tified in all conditions (Figure 2E). Minor binding-site differences
were apparent when the ‘‘siGFP-only’’ condition was analyzed,
the significance of which has yet to be explored.
Aligning the peaks across the human genome revealed that
the majority of the pRb peaks mapped to promoter and inter-
genic regions (Figures S3A and S3B). The number of pRb peaks
observed at promoter regions decreased upon H1.2 depletion,
which was accompanied by an increased association of pRb
at intergenic regions (Figures S3A and S3B). Moreover, this
was consistent with H1.2 depletion, which caused reduced
pRb enrichment at transcription start sites (Figures 3A and 3B,
i and iii). Importantly, there was a significant reduction in the as-
sociation of pRb with E2F target genes in the absence of H1.2
(from 1,056 to 283 peaks, which represents a 73% decrease;
Figures 3B, ii, and 3C), contrasting with the effect on non-E2F
regions, where the absence of H1.2 caused a proportional
increase in the binding of pRb (Figure 3C); in the absence of
H1.2, pRb binding to non-E2F genomic regions increased from
36% to 60%. Moreover, for certain E2F target genes, the level
of pRb binding was reduced in the absence of H1.2—for
example, E2F1, E2F2, CCNA2, CCNE2, EIF2S1, and BRCA2
(Figure 3D, i)—whereas for others such as PRIM1, CDT1, and
MCM4, binding was minimally affected (Figure 3D, ii). Overall,(B) Normalized coverage plots of either siGFP (red) or siH1.2 (blue) treatment a
computationally (ii), or around all peaks from the experiment (iii).
(C) Total number of pRb peaks for siH1.2 (708) and siGFP (1,650) treatment, and p
motif (blue) or not (green) are indicated.
(D) Coverage tracks around E2F target gene promoters that show a decrease in
BRCA1) (i) or no significant change (PRIM1, CDT1, and MCM4) (ii).
(E) GO analysis of pRb association with promoters in the presence and absenc
conditions (siGFP and siH1.2) and promoter regions unique to siGFP treatment a
2198 Cell Reports 19, 2193–2201, June 13, 2017these results indicate that H1.2 influences the ability of pRb to
associate with the promoter regions of E2F target genes.
Cyclin/Cdk Activity Regulates the H1-pRb Interaction
Gene Ontology (GO) analysis revealed that the most significant
group of pRb target genes affected by the loss of H1.2 was con-
nected with the cell cycle (Figure 3E). Therefore, we surmised
that the chromatin-bound H1-pRb interaction could be influ-
enced by the cell cycle, which we examined in cells that had
been growth arrested by either serum starvation or treatment
with CDK inhibitors. We performed a sequential ChIP analysis
(anti-pRb followed by anti-H1.2 or anti-pan H1 antibody) where,
in serum-starved MCF7 cells, an increased level of the chro-
matin-associated H1-pRb complex on the CDC6 promoter was
evident, compared to asynchronous cultures of growing cells
(Figures 4A and S4A, i) (as a negative control, ChIP-binding
activity to the actin promoter was assessed; Figure S4A, ii
and iii). Further, in MCF7 cells growth arrested by treatment
with the CDK inhibitor roscovitine (Meijer et al., 1997), the
H1-pRb complex was more evident in CDK-inhibitor-treated
cells (Figures 4B and S4B). These results indicate that the chro-
matin-bound H1.2-pRb complex is influenced by cell-cycle
progression, with its appearance enhanced in growth-arrested
cells. This is compatible with the biological role of pRb, which
is principally exerted at the G1-to-S phase transition (Munro
et al., 2012).
H1 Histones Influence Cell Growth
Since the ability of pRb to control cell proliferation requires pRb-
dependent regulation of E2F activity (Frolov and Dyson, 2004),
and because the transcription properties of pRb are influenced
by the interaction with H1.2, we reasoned that H1.2 may impact
on cell growth. Therefore, we developed CRISPR cell lines,
derived from U2OS (expressing WT pRb), MCF7 (expressing
WT pRb), and SAOS2 (expressing MT pRb) cells, in which we
disrupted the endogenous H1.2 gene; immunoblotting and im-
munostaining confirmed that H1.2 protein was undetectable
(Figures S4C–S4E). An analysis of chromatin-associated pRb
by ChIP analysis confirmed the earlier results (Figure 2C) that
H1.2 augments pRb binding, as pRb ChIP activity was dimin-
ished in the H1.2/ cells, compared to their WT counterparts
(Figure 4C, i). Concomitant with decreased pRb binding, the
transcriptional activity of the E2F target gene, CDC6, was
enhanced in the H1.2/ cells (Figure 4C, ii).
It was necessary to rule out the possibility that H1.2 depletion
affected the association of any transcription factor or chromatin-
associated protein with DNA and to confirm that the observed
effects were specific to pRb binding at localized regions. To
this end, ChIP analysis of SP1 and RNA polymerase II (PolII;round the transcription start site (i), around all E2F-binding motifs identified
eaks unique to siGFP (970) condition. Peaks corresponding to the E2F-binding
peak size with siH1.2 treatment (E2F1, E2F2, EIF2S1, CCNA2, CCNE2, and
e of H1.2. Comparison of pRb binding to promoter regions common to both
lone. Analysis was performed using HOMER (v.4.8).
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Figure 4. H1.2 Facilitates the Growth Regulatory Properties of pRb
(A) MCF7 cells were grown in normal growth conditions or under conditions of serum starvation for 72 hr. Chromatin extracts were immunoprecipitated with
control IgG (IgG) or pRb antibodies. ChIP re-IP was performed with the eluted IgG and pRb material with control IgG, H1.2, or H1 antibodies. Binding of the
complex to the CDC6 promoter was analyzed by qPCR.
(legend continued on next page)
Cell Reports 19, 2193–2201, June 13, 2017 2199
POLR2A) binding was performed in H1.2/ cells; significantly,
there was no effect upon H1.2 depletion on the association of
either SP1 or PolII with chromatin (Figure S4F, i and ii). We
additionally performed ChIP analysis of p53 binding to p53
target genes (where significant levels of H1 were present;
Figure S4G, i) and found that H1.2 depletion did not affect
p53 association with chromatin (Figure S4G, ii), thus confirming
the specificity of the effect of H1.2 on pRb.
An analysis of the growth properties of the H1.2/ U2OS and
H1.2/ MCF7 cells indicated that the H1.2/ cells grow faster
than their WT counterparts (at 5 and 7 days), reflecting a shorter
doubling time of the H1.2/ cells (U2OS cells: 23.8 hr compared
to 27.6 hr; Figures 4D and S4H). As anticipated, Rb/ cells also
grew faster than WT cells (Figure 4E). Moreover, a similar level of
increased proliferation was observed in cells that lack H1.2, or
both H1.2 and pRb (Figure 4E), which is consistent with pRb and
H1.2 acting through a shared mechanism and implying that H1.2
is functionally involved in pRb-dependent growth control. Further,
the increasedgrowth rate ofH1.2/ cellswas dependent onE2F1
activity, because the increase in growth rate was no longer evident
in H1.2/ cells with depleted E2F1 levels (Figure 4F).
We then used SAOS2 cells, which undergo G1 arrest upon
the expression of ectopic WT pRb (Li et al., 1995). The level of
G1 cells apparent upon WT pRb expression was compromised
in H1.2/ SAOS2 cells, compared to H1.2-expressing cells
(Figures 4G, 4H, and S4I), thus establishing a role for H1.2 in
pRb-dependent growth control. Furthermore, expression of
pRb (126-928), which is unable to bind to H1.2 (Figure 1F),
demonstrated a diminished ability to elicit G1 arrest, compared
to WT pRb in H1.2-expressing cells (Figure 4H), thus supporting
the hypothesis that the H1.2 interaction is important for pRb-
dependent growth control. In sum, these results suggest that
the linker histone, H1.2, is functionally important in mediating
the growth-regulating effects of pRb.
DISCUSSION
H1 histones have traditionally been regarded as widespread, if
not general, repressors of global transcription, mediated through(B) MCF7 cells were treated with roscovitine (20 mM) for 16 hr or were untreated. C
ChIP re-IPwasperformedwith theelutedpRbmaterialwithcontrol IgG,H1.2, orH1a
(C) In (i), pRb ChIPs in U2OSWT (WT) and U2OS H1.2/CRISPR cell lines. ChIP a
indicated E2Fpromoterswas assessedbyqPCR. (ii) U2OSWTandU2OSH1.2/
CDC6-luciferase for 48 hr, and pCMV-bGal was included to monitor transfection e
(D) U2OS WT and U2OS H1.2/ cells were seeded in triplicate. Cell counts were
shown on the right.
(E) U2OSWT, U2OS pRb/, U2OS H1.2/, and double-knockout U2OS pRb/
were performed 3, 5, and 7 days post-seeding. Corresponding immunoblots for
(F) U2OSWT and U2OSH1.2/ cells were transfected with E2F1 siRNA (20 nM) o
at a density of 1 3 104 cells in triplicate. Cell counts were performed 3, 5, and 7
(G) In (i), SAOS2 WT and SAOS2 H1.2/ CRISPR cell lines were transfected wit
cytometry analysis. Graph shows the proportion of cells in G1 phase of the cell c
(H) SAOS2 WT and SAOS2 H1.2/ CRISPR cell lines were transfected with eith
vested for flow cytometry analysis. Graph shows the fold change in cells in G1 p
(I) Model depicting the relationship between pRb and histone H1.2. H1.2 associa
silence transcription, potentially resulting in scenarios such as cell-cycle arrest, d
phosphorylated by cyclin-CDK, resulting in the dissociation of the pRb-H1.2 com
E2F and cell-cycle progression.
Data in (A)–(H) indicate average ± SD (n = 3). *p < 0.05; **p < 0.01, Student’s t te
2200 Cell Reports 19, 2193–2201, June 13, 2017their ability to compact chromatin (Misteli et al., 2000). There are,
however, an increasing number of reports that suggest that H1
histones exert gene-specific effects, which can be either positive
or negative in how they influence gene expression (Biterge and
Schneider, 2014).
We identified linker histones as interaction partners for
pRb. The interaction between H1 histone and pRb occurs on
chromatin and augments the binding of pRb to E2F target
gene promoters. We focused on the role of H1.2, which, by
genome-wide analysis of the chromatin-binding properties of
pRb by ChIP-seq, highlighted a requirement for H1.2 for the
efficient recruitment of pRb to the global network of E2F target
genes, with genes involved in cell-cycle progression being
particularly sensitive to the influence of H1.2. We propose,
therefore, that the H1.2-pRb interaction facilitates the regula-
tion, at a global level, of the E2F target gene network. The
enhanced chromatin association, which occurs in arrested
cells, is consistent with a model in which H1.2 augments tran-
scriptional repression by pRb and thereby assists cell-cycle
arrest (Figure 4I).
In conclusion, our results advance our understanding of the
biological role of H1 histones by describing a new interaction
with pRb, which enables H1.2 to influence the E2F pathway
and the expression of downstream target genes and, conse-
quently, impact cellular proliferation. Our study supports the
idea that H1 histones, while able to mediate general repressive
effects on transcription by facilitating chromatin compaction,
are, in addition, endowed with selective interaction partners,
such as pRb, which enables them to preferentially target
and regulate key gene networks, like the extensive network
controlled by the pRb-E2F pathway.
EXPERIMENTAL PROCEDURES
Expanded details of methods are listed in the Supplemental Experimental
Procedures.
Cell Culture and Transfection
U2OS, HeLa, MCF7, T98G, and SAOS2 cells were cultured in DMEM (GIBCO)
supplemented with 5% fetal bovine serum (FBS) and penicillin-streptomycinhromatin extracts were immunoprecipitated with control IgG or pRb antibodies.
ntibodies.Bindingof thecomplex to theCDC6promoterwasanalyzedbyqPCR.
nalysis was performed with either control IgG or pRb antibodies. Binding to the
CRISPRcell lineswere transfectedwith expression vectors encoding E2F-1 and
fficiency. Relative luciferase activity (luciferase units per unit of bGal) is shown.
performed at 3, 5, and 7 days post-seeding. Corresponding immunoblots are
/H1.2/ cells were seeded at a density of 23 104 cells in triplicate. Cell counts
each cell line are shown below.
r control siRNA (20 nM). 24 hr later, cells were trypsinized, counted, and seeded
days post-seeding. Corresponding immunoblots are shown below.
h either control plasmid or HA-pRb. 48 hr later, cells were harvested for flow-
ycle. (ii) Corresponding immunoblots for (i).
er control plasmid, HA-pRb, or HA-pRb (126-928). 48 hr later, cells were har-
hase of the cell cycle.
tes with pRb at E2F-regulated promoters and augments the ability of pRb to
ifferentiation, or senescence. Under conditions favorable to cell growth, pRb is
plex from chromatin and active transcription of cell-cycle-associated genes by
st.
(GIBCO) at 37C in 5% CO2. Cell lines were transfected with GeneJuice
(Novagen). Transfections included pCMV-bGal (b-galactosidase) as an
internal control to normalize transfection efficiency. For siRNA-knockdown
experiments, cells were transfected with 20 nM siRNA using Oligofectamine
Transfection Reagent (Invitrogen). siRNA sequences are available upon
request.
Antibodies
The following antibodies were used: anti-FLAG peptide monoclonal antibody
M2 (Sigma), anti-FLAG peptide monoclonal antibody M2-coupled agarose
beads (Sigma), anti-HA11 monoclonal antibody (Covance), E2F-1 (C20 and
KH95, Santa Cruz Biotechnology), pRb (4H1, Cell Signaling Technology),
G3-245 (Becton Dickinson) and IF8 (Santa Cruz), GAPDH (V18, Santa Cruz)
and b-Actin (Sigma), anti-H1.2 (ab17677 and ab4086, Abcam), anti H1.4
(from Millipore), anti-H1 (sc-8030, Santa Cruz), SP1 (sc59, Santa Cruz), and
RNA PolII (sc55492, Santa Cruz).
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